GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (ASX:CSL) » Definitions » Investments And Advances

CSL (ASX:CSL) Investments And Advances : A$241 Mil (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is CSL Investments And Advances?

CSL's Investments And Advances for the quarter that ended in Dec. 2023 was A$241 Mil.

CSL's quarterly Investments And Advances declined from Dec. 2022 (A$348 Mil) to Jun. 2023 (A$258 Mil) and declined from Jun. 2023 (A$258 Mil) to Dec. 2023 (A$241 Mil).

CSL's annual Investments And Advances increased from Jun. 2021 (A$28 Mil) to Jun. 2022 (A$573 Mil) but then declined from Jun. 2022 (A$573 Mil) to Jun. 2023 (A$258 Mil).

CSL Investments And Advances Historical Data

The historical data trend for CSL's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Investments And Advances Chart

CSL Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.26 20.58 28.12 573.33 257.77

CSL Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.08 573.33 347.83 257.77 240.53

CSL Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

CSL (ASX:CSL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (ASX:CSL) » Definitions » Investments And Advances
Comparable Companies
ASX:TLX ASX:NEU ASX:MSB ASX:CU6 ASX:CUV ASX:IMU ASX:IMM ASX:OPT ASX:PYC ASX:BOT OCSE:NOVO B VRTX REGN MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX OCSE:GMAB
Traded in Other Exchanges
CSLLY:USA CMXHF:USA CSJ:Germany
Address
655 Elizabeth Street, Melbourne, VIC, AUS, 3000
Website
https://www.csl.com
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.